Full name: Thierry L. Bernard

Title: Chief Executive Officer

Website: https://www.qiagen.com/us

Ticker: $QGEN

Biography:

Thierry Bernard joined QIAGEN in February 2015 to lead the company’s growing presence in molecular diagnostics, the application of Sample to Insight solutions for molecular testing in human healthcare.

He was named Chief Executive Officer in March 2020 after serving in this role on an interim basis and became a member of the Managing Board in 2021.

Previously, Mr. Bernard held roles of increasing responsibility during 15 years with bioMérieux SA, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region, and held senior management roles in several other leading international companies.

He was named Chair of the AdvaMedDx Board of Directors in March 2023, a U.S. industry trade association, and joined the Board of Directors of Neogen Corporation (NASDAQ: NEOG) in 2024.

Mr. Bernard has earned degrees and certifications from Sciences Po, the London School of Economics, the College of Europe, Harvard Business School, Centro de Comercio Exterior de Barcelona. He has been appointed Conseiller du Commerce Extérieur by the French government.